Mutual of Omaha Final Expense Insurance Fit Review for People With Diabetes

Research Snapshot

Why Mutual of Omaha Qualified for This Study

Questions This Section Answers

• Why did Mutual of Omaha qualify for this final expense insurance study for people with diabetes?
• How many AI platforms named Mutual of Omaha for diabetic final expense coverage?

Mutual of Omaha qualified because every included platform named it during ranking discovery, and it placed first overall. The ranking stage counted 7 platform mentions across 7 included platforms, a 100% share, with an average listed rank of 1.86 and a best rank of 1 (deepseek, grok, kimi, perplexity). Its ranks by platform were: deepseek 1, grok 1, kimi 1, perplexity 1, google 2, openai 3, anthropic 4.

The platforms converged on the same product family. Six of seven named Living Promise Whole Life or a Living Promise tier as the relevant plan; openai and perplexity also flagged Guaranteed Whole Life as a fallback, and deepseek described it as the guaranteed-issue option within the same brand ^[1]. Fit ratings were "good" from anthropic, deepseek, google, grok, openai, and perplexity, and "strong" from kimi.

Qualification does not prove product quality. It means the platforms repeatedly associated Mutual of Omaha with this specific buyer situation. The consensus index for this category is available at Final Expense Insurance for People With Diabetes, and the broader life insurance directory lists related categories.

The Product, Model, Plan, or Service Most Relevant to Final Expense Insurance for People With Diabetes

Questions This Section Answers

• Which Mutual of Omaha plan is most relevant for a senior with diabetes who needs $15,000 to $25,000 of final expense coverage?
• Does Mutual of Omaha Living Promise require a medical exam for a diabetic applicant?

The most relevant product is Living Promise Whole Life, specifically the Level Benefit tier, with the Graded Benefit tier and Guaranteed Whole Life as fallbacks. Living Promise is a simplified-issue whole life policy designed for final expenses, with no medical exam; eligibility is determined by answers to health questions ^[4].

Face amounts and ages vary by source. The producer product sheet cited by openai lists Level Benefit face amounts of $2,000–$50,000, while the Graded Benefit plan lists $2,000–$20,000 ^[9]. Anthropic's sources describe $2,000–$40,000 for Level Benefit and $2,000–$20,000 for Graded, ages 45–85 ^[5]. Google's sources cite Level Benefit at $2,000–$40,000 for ages 45–85 and Graded at $2,000–$20,000 for ages 45–80 ^[11]. Kimi describes small whole life policies from $5,000 to $50,000 ^[13]. The buyer's $15,000–$25,000 target fits inside every version of the Level Benefit range, but the Graded maximum of $20,000 would not reach $25,000.

Guaranteed Whole Life is a separate product. Mutual of Omaha markets it as guaranteed-issue whole life with no health questions, generally for ages 45–85 with coverage of $2,000–$25,000, subject to state variation ^[14]. It is not the same contract as Living Promise, and the two should not be conflated.

What the AI Platforms Agreed About

Questions This Section Answers

• What do AI platforms agree on about Mutual of Omaha Living Promise for well-managed diabetes?
• Is Mutual of Omaha Living Promise permanent whole life coverage with level premiums for diabetic applicants?

The platforms agreed on five points.

First, the product is permanent whole life insurance, not term. Living Promise is whole life: premiums are level and never increase, the death benefit does not decrease, coverage does not expire at a set age, and the policy builds cash value ^[17].

Second, underwriting is simplified issue with no medical exam. Applicants answer health questions, and the carrier runs MIB and pharmacy database checks ^[21].

Third, the Level Benefit tier pays full benefits from day one, while the Graded Benefit tier imposes a two-year limited natural-death benefit, typically returning premiums plus a percentage ^[26].

Fourth, well-controlled Type 2 diabetes without complications is the profile most likely to reach Level Benefit. Independent agent guidance cited by perplexity says Type 2 diabetes on oral medication without complications is typically eligible for Living Promise Level ^[29]. Anthropic's sources state that diabetics using pills or insulin are considered for Level coverage when diagnosed at age 50 or older ^[30].

Fifth, diabetic complications are the main obstacle. Neuropathy, retinopathy, nephropathy, and peripheral vascular disease are repeatedly described as pushing applicants to Graded or decline ^[32].

Where the AI Platforms Disagreed or Were Uncertain

Questions This Section Answers

• What is the exact age-of-diagnosis cutoff that keeps a diabetic applicant eligible for Mutual of Omaha Living Promise Level Benefit?
• Does Mutual of Omaha offer a guaranteed-issue final expense product for diabetics who fail Living Promise underwriting?

The platforms disagreed or were uncertain on five material points.

Age-of-diagnosis thresholds conflict. One Mutual of Omaha simplified-underwriting guide states diabetes diagnosed before age 45 is a decline ^[36]. Another source indicates diabetes diagnosed after age 45 with certain build thresholds is uninsurable ^[37]. Google's sources say diagnosis before age 49 leads to a Graded rating, and diagnosis before age 50 is excluded from first-day Level coverage ^[38]. The boundary between ages 45 and 50 is not resolved in the supplied evidence.

Insulin treatment is contested. Deepseek cites a Mutual of Omaha underwriting guide stating a preferred rate class is not available for insulin-treated diabetics ^[40]. Kimi, by contrast, describes Level day-one coverage as available for many insulin users without paired complications or recent hospitalization ^[41]. These are not reconcilable from the supplied material.

Guaranteed-issue availability is unclear. Deepseek and perplexity both identify Guaranteed Whole Life as a Mutual of Omaha fallback ^[42]. Kimi states that whether Mutual of Omaha offers any guaranteed-issue final expense product at all is unclear from its sources, and that AIG and Gerber appear to fill that role ^[44].

Underwriting strictness is characterized differently. Anthropic's sources call Mutual of Omaha the strictest in the final expense market on health questions, more restrictive than Aetna, Transamerica, AIG, or Aflac ^[45]. Other sources describe it as generous relative to fully underwritten carriers. Both can be true depending on the comparison set.

Pricing is not publicly confirmed. No platform produced a carrier-confirmed premium for a diabetic applicant at $15,000–$25,000. Deepseek's research ran without search enabled and is dated 2026-02-14, seven months before the authoritative run date; its claims are platform-reported and should be verified before being treated as current.

Use-Case-Specific Features and Capabilities

Questions This Section Answers

• What features does Mutual of Omaha Living Promise offer a diabetic buyer who needs day-one coverage?
• Does Mutual of Omaha Living Promise include an accelerated death benefit for terminal illness or nursing home confinement?

The features most relevant to this buyer are the two-tier benefit structure, the no-exam application, the accelerated death benefit, and the guaranteed-issue fallback.

The Level Benefit tier pays the full death benefit from day one with no waiting period ^[47]. The Graded Benefit tier limits the natural-death benefit during the first two years, typically returning premiums plus a percentage, with full benefits after 24 months; accidental death generally pays the full benefit in all years ^[47]. The producer product sheet cited by openai states the Level Benefit policy is guaranteed to age 100 while premiums are paid and includes an accelerated death benefit for terminal illness or nursing-home confinement, with an optional accidental-death rider ^[50]. Anthropic's sources describe the accelerated death benefit rider as included at no extra cost on the Level plan ^[51].

Application is through a licensed agent; Mutual of Omaha does not sell Living Promise directly online or by phone to the company ^[52]. Approvals are typically reported within 24–48 hours ^[52]. The carrier is A+ rated by A.M. Best according to multiple sources, and most claims are reported paid within 24 hours ^[53].

State availability matters. Level Benefit is described as available in all states except New York, with Graded available in New York at reduced ages ^[56]. Product provisions, riders, and limits vary by state ^[57].

Pricing, Fees, Contracts, and Ongoing Costs

Questions This Section Answers

• How much does Mutual of Omaha Living Promise cost per month for a diabetic senior seeking $15,000 to $25,000 of coverage?
• What fees and loan charges apply to a Mutual of Omaha Living Promise policy?

No carrier-confirmed premium for a diabetic applicant at $15,000–$25,000 was available from any platform. Pricing confidence was rated low by openai, deepseek, and perplexity, and moderate by anthropic, grok, and kimi.

The concrete cost data points that were supplied: a $36 annual policy fee on the Level Benefit plan and a 7.4% policy-loan charge in advance, both from the producer product sheet cited by openai ^[59]. Grok cites an example of approximately $41 per month for a 65-year-old female at $10,000 of Level coverage ^[60]. Google cites a sample rate of approximately $83.12 per month for a 65-year-old male at $15,000 ^[62]. Kimi publishes an age-banded table for $10,000 of coverage: age 50 female/male $24/$31, age 60 $33/$43, age 65 $41/$56, age 70 $53/$74, age 75 $72/$99, age 80 $98/$139 ^[61]. These are third-party sample rates, not carrier-confirmed quotes, and they should not be treated as the buyer's price.

Cost multipliers reported across platforms: Graded Benefit rates run roughly 2–3× Level Benefit at the same coverage ^[63], tobacco users pay roughly 30–50% more than non-tobacco rates ^[64], and diabetic applicants generally pay 10–30% above non-diabetic baselines depending on tier and control ^[65]. Final expense is priced per $1,000 of coverage, so a $15,000 policy costs roughly 1.5× the $10,000 rate ^[66].

Contract terms: premiums are locked at issue and never increase; coverage remains in force for life while premiums are paid; a grace period applies if a premium is missed, and reinstatement may require proof of insurability ^[67]. Free-look and cancellation rules vary by state ^[69]. Policy loans reduce cash value and the death benefit if outstanding ^[59].

Best Suited For

Questions This Section Answers

• Who is Mutual of Omaha Living Promise best suited for among seniors with diabetes?
• Is Mutual of Omaha a good choice for a Type 2 diabetic diagnosed after age 50 with no complications?

Mutual of Omaha is best suited for a senior with well-controlled Type 2 diabetes, diagnosed at or after age 50, with no diabetic complications, who wants $15,000–$25,000 of permanent coverage and prefers no medical exam. That profile is the one most consistently described as reaching Level Benefit with day-one full coverage ^[70].

It also suits buyers who want a fixed premium that never increases, lifetime coverage that does not expire, and a carrier with an A+ financial-strength rating ^[73]. It suits buyers who value a same-brand fallback: if health answers prevent Level Benefit, the Graded Benefit tier or Guaranteed Whole Life may still provide coverage ^[75].

It suits applicants who are willing to work through a licensed agent, since Living Promise cannot be purchased directly from the company ^[77].

Probably Not Best Suited For

Questions This Section Answers

• Who should not choose Mutual of Omaha Living Promise for final expense coverage with diabetes?
• Is Mutual of Omaha a poor fit for a diabetic with neuropathy, retinopathy, or a recent diabetes-related hospitalization?

Mutual of Omaha is probably not the best fit for applicants with diabetic complications who need immediate full benefits. Neuropathy, retinopathy, nephropathy, and peripheral vascular disease are repeatedly described as excluding applicants from Level Benefit and routing them to Graded or decline ^[78].

It is probably not the best fit for applicants with a history of insulin shock, diabetic coma, or diabetes-related amputation. Google's sources place these in the application's knockout section, resulting in decline of both Level and Graded coverage ^[82]. Kimi similarly reports that diabetes-related amputation and diabetes-related hospitalization within the past 12 months typically disqualify from Level coverage ^[84].

It is probably not the best fit for early-onset diabetes. Diagnosis before age 45 is described as a decline in one underwriting guide, and diagnosis before age 49–50 is described as forcing Graded placement ^[86].

It is probably not the best fit for buyers who need more than the applicable face-amount limit, who need guaranteed acceptance with no health questions at all, or who want the lowest possible premium and may qualify for fully underwritten traditional coverage ^[88].

When Another Option May Be Better

Questions This Section Answers

• What is a better alternative to Mutual of Omaha for a diabetic with complications who needs day-one full coverage?
• When should a diabetic buyer choose a guaranteed-issue carrier instead of Mutual of Omaha Living Promise?

Another option may be better in five situations.

If the applicant has diabetic complications and wants day-one full benefits, anthropic's sources name Aetna/Accendo, Transamerica, and AIG as having more lenient underwriting that may place such applicants in a Level tier ^[90]. Kimi names Transamerica Express Select, Aetna Accendo, and Aflac for paired complications ^[92].

If the applicant was declined by Mutual of Omaha, the same carriers are described as having demonstrably more lenient underwriting for similar profiles ^[90].

If the applicant needs true guaranteed issue with no health questions, AIG Corebridge and Gerber Life are named as more lenient guaranteed-issue carriers, though premiums run 30–60% higher than simplified-issue alternatives ^[92].

If the applicant lives in New York and wants Level Benefit, Living Promise Level is not available there; guaranteed-issue whole life from Mutual of Omaha or a competitor is the described path ^[94].

If the applicant needs coverage above the applicable face-amount limit, Foresters, AIG, and specialty carriers are described as offering $50,000 or more at limited issue ages ^[90].

Questions to Verify Before Buying

Questions This Section Answers

• What should a diabetic buyer confirm with Mutual of Omaha before signing a Living Promise application?
• Which policy form and underwriting tier will Mutual of Omaha actually issue to a diabetic applicant?

Confirm the following with a licensed agent before applying.

Which policy form is being offered in your state: Living Promise Level Benefit, Living Promise Graded Benefit, Guaranteed Whole Life, or another form ^[95].

Whether your specific diabetes profile qualifies for Level Benefit, including diabetes type, diagnosis date, A1C or other control information, current medications including insulin, and any complications ^[97].

The exact monthly and annual premium for $15,000, $20,000, and $25,000, including the $36 annual policy fee and any rider costs ^[100].

Whether the quoted premium is guaranteed level for life and under what circumstances the policy could lapse or require change ^[101].

If you qualify only for Graded or Guaranteed Whole Life, exactly what is payable for natural death in each of the first two policy years ^[102].

Whether state-specific exclusions, benefit reductions, rider restrictions, or face-amount limits apply ^[104].

The cash-value schedule, loan interest terms, surrender values, and the effect of an outstanding loan ^[100].

Which company is the contractual insurer and what policy form and state filing govern the application ^[95].

Whether the agent can provide a side-by-side quote from at least two carriers using the same coverage amount and the same diabetes information ^[106].

Final AI Consensus Verdict

Mutual of Omaha is a good fit for this buyer, with conditions. All seven included platforms named it, it finished first overall, and six of seven rated the fit "good" with one "strong." The Living Promise Level Benefit plan can provide $15,000–$25,000 of permanent, no-exam coverage with day-one full benefits for a well-controlled Type 2 diabetic diagnosed at or after age 50 with no complications. The Graded Benefit tier and Guaranteed Whole Life provide fallbacks when health answers prevent Level eligibility.

The conditions are material. Diabetes-specific acceptance and pricing are not publicly established. Insulin-treated diabetics may be excluded from preferred classes. Complications such as neuropathy, retinopathy, and nephropathy are repeatedly described as forcing graded placement or decline. Severe complications including amputation, insulin shock, and diabetic coma are described as declines. No individualized premium was verifiable from any platform. Buyers should treat Mutual of Omaha as a strong first quote to test, not as a guaranteed approval, and should compare a state-specific quote against competing carriers before committing.

How This Review Was Produced

This review was produced from a structured multi-platform research run dated 2026-09-22. Seven AI platforms were included: anthropic, deepseek, google, grok, kimi, openai, and perplexity. Each platform was asked which life insurance carriers it would recommend for a senior with diabetes seeking approximately $15,000–$25,000 of permanent final expense coverage, and why. Mutual of Omaha was named by all seven platforms during the ranking stage, with an average listed rank of 1.86 and a best rank of 1. Each platform then supplied a fit assessment, product identification, pricing and terms, limitations, and questions to verify before buying. Those outputs were consolidated into this review. Citations are platform-reported evidence and were not independently verified by the writer stage.

Methodology Limitations

Platform-reported research dates differ from the authoritative run date of 2026-09-22. Six platforms reported 2026-09-23; deepseek reported 2026-02-14. Platform-reported dates are provenance metadata and do not independently prove freshness.

Deepseek's research ran with search disabled, so its claims are platform-reported and require verification before being described as current facts.

The supplied URLs were collected from platform responses and were not independently validated by the writer stage.

Official-site retrieval failed for one or more mentions during the deterministic identity audit; no failed fetch was used as a verified domain key. A product-labeled company mention was merged using matching company-name and supplied-domain signatures.

Product names, face-amount limits, and age ranges conflict across sources and were not resolved by guessing. The exact policy form available to a given buyer is unclear without a state-specific illustration or application.

Current diabetes underwriting criteria, rate classes, exclusions, and prescription-history rules were not publicly verified. Current individualized pricing was not available from the public sources reviewed.

Platform agreement does not prove product quality. It indicates that multiple AI systems associated Mutual of Omaha with this buyer situation.